Research ExplorerScientific StaffMarianne Sinn Publications

PD Dr. ID: 6360691

Marianne Sinn

graph of relations
Affiliations
1 - 50 out of 78Page size: 50

Publications

  1. 2012

  2. Biliary tract cancer: a survey regarding the current oncological daily care practice in Germany

    Sinn, M., Bischoff, S., Nehls, O., Pelzer, U., von Weizsäcker, F., Kubicka, S., Stieler, J. M., Caca, K. & Riess, H., 2012, In: ONKOLOGIE. 35, 12, p. 755-60 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Computed tomography-guided interstitial HDR brachytherapy (CT-HDRBT) of the liver in patients with irresectable intrahepatic cholangiocarcinoma

    Schnapauff, D., Denecke, T., Grieser, C., Collettini, F., Colletini, F., Seehofer, D., Sinn, M., Banzer, J., Lopez-Hänninen, E., Hamm, B., Wust, P. & Gebauer, B., 06.2012, In: CARDIOVASC INTER RAD. 35, 3, p. 581-7 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. 2013

  5. Blood group determinates incidence for pancreatic cancer in Germany

    Pelzer, U., Klein, F., Bahra, M., Sinn, M., Dörken, B., Neuhaus, P., Meyer, O. & Riess, H., 2013, In: FRONT PHYSIOL. 4, p. 118

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Value of carbohydrate antigen 19-9 in predicting response and therapy control in patients with metastatic pancreatic cancer undergoing first-line therapy

    Pelzer, U., Hilbig, A., Sinn, M., Stieler, J., Bahra, M., Dörken, B. & Riess, H., 2013, In: FRONT ONCOL. 3, p. 155

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Hepatic arterial infusion with oxaliplatin and 5-FU/folinic acid for advanced biliary tract cancer: a phase II study

    Sinn, M., Nicolaou, A., Gebauer, B., Podrabsky, P., Seehofer, D., Ricke, J., Dörken, B., Riess, H. & Hildebrandt, B., 08.2013, In: DIGEST DIS SCI. 58, 8, p. 2399-405 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with primary liver cancer: a phase II-study (NCT00356161)

    Sinn, M., Nicolaou, A., Ricke, J., Podrabsky, P., Seehofer, D., Gebauer, B., Pech, M., Neuhaus, P., Dörken, B., Riess, H. & Hildebrandt, B., 09.08.2013, In: BMC GASTROENTEROL. 13, p. 125

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Primäre medikamentöse Thromboembolieprophylaxe bei ambulanten Patienten mit fortgeschrittenem Pankreaskarzinom unter Chemotherapie?

    Pelzer, U., Sinn, M., Stieler, J. & Riess, H., 10.2013, In: DEUT MED WOCHENSCHR. 138, 41, p. 2084-8 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: Results from the CONKO-001 study

    Oettle, H., Neuhaus, P., Hochhaus, A., Hartmann, J. T., Gellert, K., Ridwelski, K., Niedergethmann, M., Zülke, C., Fahlke, J., Arning, M. B., Sinn, M., Hinke, A. & Riess, H., 09.10.2013, In: JAMA-J AM MED ASSOC. 310, 14, p. 1473-81 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Does long-term survival in patients with pancreatic cancer really exist? Results from the CONKO-001 study

    Sinn, M., Striefler, J. K., Sinn, B. V., Sallmon, D., Bischoff, S., Stieler, J. M., Pelzer, U., Bahra, M., Neuhaus, P., Dörken, B., Denkert, C., Riess, H. & Oettle, H., 11.2013, In: J SURG ONCOL. 108, 6, p. 398-402 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. 2014

  13. Intensity-modulated and image-guided radiotherapy in patients with locally advanced inoperable pancreatic cancer after preradiation chemotherapy

    Sinn, M., Ganeshan, R., Graf, R., Pelzer, U., Stieler, J. M., Striefler, J. K., Bahra, M., Wust, P. & Riess, H., 2014, In: SCI WORLD J. 2014, p. 452089

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Multimodale Therapie des Pankreaskarzinoms

    Pelzer, U., Sinn, M., Stieler, J. & Riess, H., 01.2014, In: INTERNIST. 55, 1, p. 31-6 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Intensified chemotherapy and simultaneous treatment with heparin in outpatients with pancreatic cancer - the CONKO 004 pilot trial

    Pelzer, U., Hilbig, A., Stieler, J. M., Bahra, M., Sinn, M., Gebauer, B., Dörken, B. & Riess, H., 19.03.2014, In: BMC CANCER. 14, p. 204

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. KRAS mutations in codon 12 or 13 are associated with worse prognosis in pancreatic ductal adenocarcinoma

    Sinn, B. V., Striefler, J. K., Rudl, M. A., Lehmann, A., Bahra, M., Denkert, C., Sinn, M., Stieler, J., Klauschen, F., Budczies, J., Weichert, W., Stenzinger, A., Kamphues, C., Dietel, M. & Riess, H., 05.2014, In: PANCREAS. 43, 4, p. 578-83 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Second-line oxaliplatin, folinic acid, and fluorouracil versus folinic acid and fluorouracil alone for gemcitabine-refractory pancreatic cancer: outcomes from the CONKO-003 trial: outcomes from the CONKO-003 trial

    Oettle, H., Riess, H., Stieler, J. M., Heil, G., Schwaner, I., Seraphin, J., Görner, M., Mölle, M., Greten, T. F., Lakner, V., Bischoff, S., Sinn, M., Dörken, B. & Pelzer, U., 10.08.2014, In: J CLIN ONCOL. 32, 23, p. 2423-9 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. α-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study

    Sinn, M., Denkert, C., Striefler, J. K., Pelzer, U., Stieler, J. M., Bahra, M., Lohneis, P., Dörken, B., Oettle, H., Riess, H. & Sinn, B. V., 11.11.2014, In: BRIT J CANCER. 111, 10, p. 1917-23 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. 2015

  20. Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial

    Pelzer, U., Opitz, B., Deutschinoff, G., Stauch, M., Reitzig, P. C., Hahnfeld, S., Müller, L., Grunewald, M., Stieler, J. M., Sinn, M., Denecke, T., Bischoff, S., Oettle, H., Dörken, B. & Riess, H., 20.06.2015, In: J CLIN ONCOL. 33, 18, p. 2028-34 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Prognostic significance of DNA cytometry for adjuvant therapy response in pancreatic cancer

    Klein, F., Bahra, M., Schirmeier, A., Al-Abadi, H., Pratschke, J., Pelzer, U., Oettle, H., Striefler, J., Riess, H. & Sinn, M., 07.2015, In: J SURG ONCOL. 112, 1, p. 66-71 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Cytoreductive Surgery for Pancreatic Cancer Improves Overall Outcome of Gemcitabine-Based Chemotherapy

    Bahra, M., Pratschke, J., Klein, F., Neuhaus, P., Boas-Knoop, S., Puhl, G., Denecke, T., Pullankavumkal, J. R., Sinn, M., Riess, H. & Pelzer, U., 08.2015, In: PANCREAS. 44, 6, p. 930-6 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine - Results from the CONKO-001 trial

    Sinn, M., Riess, H., Sinn, B. V., Stieler, J. M., Pelzer, U., Striefler, J. K., Oettle, H., Bahra, M., Denkert, C., Bläker, H. & Lohneis, P., 08.2015, In: EUR J CANCER. 51, 12, p. 1546-54 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. 2016

  25. Perioperative treatment options in resectable pancreatic cancer - how to improve long-term survival

    Sinn, M., Bahra, M., Denecke, T., Travis, S., Pelzer, U. & Riess, H., 15.03.2016, In: WORLD J GASTRO ONCOL. 8, 3, p. 248-57 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  26. Primary prevention and treatment of venous thromboembolic events in patients with gastrointestinal cancers - Review

    Riess, H., Habbel, P., Jühling, A., Sinn, M. & Pelzer, U., 15.03.2016, In: WORLD J GASTRO ONCOL. 8, 3, p. 258-70 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  27. Second-Line Treatment in Pancreatic Cancer Patients: Who Profits?--Results From the CONKO Study Group

    Sinn, M., Dälken, L., Striefler, J. K., Bischoff, S., Schweitzer, N., Pelzer, U., Dörken, B., Riess, H. & Stieler, J. M., 04.2016, In: PANCREAS. 45, 4, p. 601-5 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. P53 overexpression and Ki67-index are associated with outcome in ductal pancreatic adenocarcinoma with adjuvant gemcitabine treatment

    Striefler, J. K., Sinn, M., Pelzer, U., Jühling, A., Wislocka, L., Bahra, M., Sinn, B. V., Denkert, C., Dörken, B., Oettle, H., Riess, H., Bläker, H. & Lohneis, P., 08.2016, In: PATHOL RES PRACT. 212, 8, p. 726-34 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Einsatz von Neuen oralen Antikoagulanzien (NOAK) bei onkologischen Patienten

    Trappe, R. U., Sinn, M. & Riess, H., 09.2016, In: DEUT MED WOCHENSCHR. 141, 20, p. 1446-1450 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  30. Resting heart rate is an independent predictor of death in patients with colorectal, pancreatic, and non-small cell lung cancer: results of a prospective cardiovascular long-term study

    Anker, M. S., Ebner, N., Hildebrandt, B., Springer, J., Sinn, M., Riess, H., Anker, S. D., Landmesser, U., Haverkamp, W. & von Haehling, S., 12.2016, In: EUR J HEART FAIL. 18, 12, p. 1524-1534 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. 2017

  32. Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients

    Zschaeck, S., Blümke, B., Wust, P., Kaul, D., Bahra, M., Riess, H., Klein, F., Sinn, M., Pelzer, U., Budach, V. & Ghadjar, P., 2017, In: PLOS ONE. 12, 10, p. e0186341

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma

    Lohneis, P., Sinn, M., Bischoff, S., Jühling, A., Pelzer, U., Wislocka, L., Bahra, M., Sinn, B. V., Denkert, C., Oettle, H., Bläker, H., Riess, H., Jöhrens, K. & Striefler, J. K., 09.2017, In: EUR J CANCER. 83, p. 290-301 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resection

    Duwe, G., Knitter, S., Pesthy, S., Beierle, A. S., Bahra, M., Schmelzle, M., Schmuck, R. B., Lohneis, P., Raschzok, N., Öllinger, R., Sinn, M., Struecker, B., Sauer, I. M., Pratschke, J. & Andreou, A., 09.2017, In: EJSO-EUR J SURG ONC. 43, 9, p. 1668-1681 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  35. Incidence and Oncological Implications of Previously Undetected Tumor Multicentricity Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in Patients Undergoing Salvage Pancreatectomy

    Andreou, A., Klein, F., Schmuck, R. B., Lee, D., Sinn, M., Denecke, T., Pratschke, J. & Bahra, M., 09.2017, In: ANTICANCER RES. 37, 9, p. 5269-5275 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial

    Sinn, M., Bahra, M., Liersch, T., Gellert, K., Messmann, H., Bechstein, W., Waldschmidt, D., Jacobasch, L., Wilhelm, M., Rau, B. M., Grützmann, R., Weinmann, A., Maschmeyer, G., Pelzer, U., Stieler, J. M., Striefler, J. K., Ghadimi, M., Bischoff, S., Dörken, B., Oettle, H. & Riess, H., 10.10.2017, In: J CLIN ONCOL. 35, 29, p. 3330-3337 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. SPARC expression in resected pancreatic cancer patients treated with Gemcitabine: results from the CONKO-001 study

    Sinn, M., Sinn, B. V., Striefler, J. K., Lindner, J. L., Stieler, J. M., Lohneis, P., Bischoff, S., Bläker, H., Pelzer, U., Bahra, M., Dietel, M., Dörken, B., Oettle, H., Riess, H. & Denkert, C., 01.11.2017, In: ANN ONCOL. 28, 11, p. 2900

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Risk estimation for biliary tract cancer: Development and validation of a prognostic score

    Schweitzer, N., Fischer, M., Kirstein, M. M., Berhane, S., Kottas, M., Sinn, M., Gonzalez-Carmona, M. A., Balta, Z., Weismüller, T. J., Strassburg, C. P., Reineke-Plaaß, T., Bektas, H., Manns, M. P., Johnson, P., Weinmann, A. & Vogel, A., 12.2017, In: LIVER INT. 37, 12, p. 1852-1860 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. 2018

  40. Two patients with rare mixed adenoneuroendocrine carcinomas of the rectum

    Gül-Klein, S., Sinn, M., Jurmeister, P. S., Biebl, M., Weiß, S., Rau, B., Bläker, H., Pratschke, J. & Aigner, F., 2018, In: SAGE OPEN MED CASE R. 6, p. 2050313X18758816

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer-a randomised biomarker-driven clinical phase II AIO study

    Vogel, A., Kasper, S., Bitzer, M., Block, A., Sinn, M., Schulze-Bergkamen, H., Moehler, M., Pfarr, N., Endris, V., Goeppert, B., Merx, K., Schnoy, E., Siveke, J. T., Michl, P., Waldschmidt, D., Kuhlmann, J., Geissler, M., Kahl, C., Evenkamp, R., Schmidt, T., Kuhlmann, A., Weichert, W. & Kubicka, S., 03.2018, In: EUR J CANCER. 92, p. 11-19 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma

    Lohneis, P., Sinn, M., Klein, F., Bischoff, S., Striefler, J. K., Wislocka, L., Sinn, B. V., Pelzer, U., Oettle, H., Riess, H., Denkert, C., Bläker, H. & Jühling, A., 05.2018, In: BRIT J CANCER. 118, 11, p. 1485-1491 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis

    Arends, C. M., Galan-Sousa, J., Hoyer, K., Chan, W., Jäger, M., Yoshida, K., Seemann, R., Noerenberg, D., Waldhueter, N., Fleischer-Notter, H., Christen, F., Schmitt, C. A., Dörken, B., Pelzer, U., Sinn, M., Zemojtel, T., Ogawa, S., Märdian, S., Schreiber, A., Kunitz, A., Krüger, U., Bullinger, L., Mylonas, E., Frick, M. & Damm, F., 09.2018, In: LEUKEMIA. 32, 9, p. 1908-1919 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Safety and efficacy of Nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer suffering from cholestatic hyperbilirubinaemia-A retrospective analysis

    Pelzer, U., Wislocka, L., Jühling, A., Striefler, J., Klein, F., Roemmler-Zehrer, J., Sinn, M., Denecke, T., Bahra, M. & Riess, H., 09.2018, In: EUR J CANCER. 100, p. 85-93 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. 2019

  46. Position of Scientific Oncological Societies Towards Biosimilar Antibodies

    Wörmann, B. & Sinn, M., 03.2019, In: BREAST CARE. 14, 1, p. 5-8 4 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  47. 2020

  48. Gallengangs- und Gallenblasenkarzinome: auf dem Weg zur personalisierten Therapie

    Sinn, M., Wege, H. & Stein, A., 04.2020, In: DEUT MED WOCHENSCHR. 145, 7, p. 442-446 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. TP53 mutations predict sensitivity to adjuvant gemcitabine in patients with pancreatic ductal adenocarcinoma: next-generation sequencing results from the CONKO-001 trial

    Sinn, M., Sinn, B. V., Treue, D., Keilholz, U., Damm, F., Schmuck, R. B., Lohneis, P., Klauschen, F., Striefler, J. K., Bahra, M., Bläker, H., Bischoff, S., Pelzer, U., Oettle, H., Riess, H., Budczies, J. & Denkert, C., 15.07.2020, In: CLIN CANCER RES. 26, 14, p. 3732-3739 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer - Final results

    Sinn, M., Liersch, T., Riess, H., Gellert, K., Stübs, P., Waldschmidt, D., Lammert, F., Maschmeyer, G., Bechstein, W., Bitzer, M., Denzlinger, C., Hofheinz, R., Lindig, U., Ghadimi, M., Hinke, A., Striefler, J. K., Pelzer, U., Bischoff, S., Bahra, M. & Oettle, H., 10.2020, In: EUR J CANCER. 138, p. 172-181 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper

    Wörmann, B., Bokemeyer, C., Burmeister, T., Köhne, C-H., Schwab, M., Arnold, D., Blohmer, J-U., Borner, M., Brucker, S., Cascorbi, I., Decker, T., de Wit, M., Dietz, A., Einsele, H., Eisterer, W., Folprecht, G., Hilbe, W., Hoffmann, J., Knauf, W., Kunzmann, V., Largiadèr, C. R., Lorenzen, S., Lüftner, D., Moehler, M., Nöthen, M. M., Pox, C., Reinacher-Schick, A., Scharl, A., Schlegelberger, B., Seufferlein, T., Sinn, M., Stroth, M., Tamm, I., Trümper, L., Wilhelm, M., Wöll, E. & Hofheinz, R-D., 23.10.2020, In: ONCOL RES TREAT. 43, 11, p. 628-636 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  52. Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II Study

    Pape, U-F., Kasper, S., Meiler, J., Sinn, M., Vogel, A., Müller, L., Burkhard, O., Caca, K., Heeg, S., Büchner-Steudel, P., Rodriguez-Laval, V., Kühl, A. A., Arsenic, R., Jansen, H., Treasure, P. & Utku, N., 27.10.2020, In: CANCERS. 12, 11

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. 2021

  54. Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study

    Striefler, J. K., Riess, H., Lohneis, P., Bischoff, S., Kurreck, A., Modest, D. P., Bahra, M., Oettle, H., Sinn, M., Bläker, H., Denkert, C., Stintzing, S., Sinn, B. V. & Pelzer, U., 2021, In: FRONT ONCOL. 11, 670396.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  55. A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial

    Hoyer, K., Hablesreiter, R., Inoue, Y., Yoshida, K., Briest, F., Christen, F., Kakiuchi, N., Yoshizato, T., Shiozawa, Y., Shiraishi, Y., Striefler, J. K., Bischoff, S., Lohneis, P., Putter, H., Blau, O., Keilholz, U., Bullinger, L., Pelzer, U., Hummel, M., Riess, H., Ogawa, S., Sinn, M. & Damm, F., 04.2021, In: EBIOMEDICINE. 66, 103327.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  56. Impact of completeness of adjuvant gemcitabine, relapse pattern, and subsequent therapy on outcome of patients with resected pancreatic ductal adenocarcinoma - A pooled analysis of CONKO-001, CONKO-005, and CONKO-006 trials

    Kurreck, A., Weckwerth, J., Modest, D. P., Striefler, J. K., Bahra, M., Bischoff, S., Pelzer, U., Oettle, H., Kruger, S., Riess, H. & Sinn, M., 06.2021, In: EUR J CANCER. 150, p. 250-259 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  57. Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patients with Multiple Myeloma Correlates with Low CD19+ B-Lymphocyte Count and Anti-CD38 Treatment

    Ghandili, S., Schönlein, M., Lütgehetmann, M., Wiesch, J. S. Z., Becher, H., Bokemeyer, C., Sinn, M., Weisel, K. C. & Leypoldt, L. B., 28.07.2021, In: CANCERS. 13, 15, 3800.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  58. Effects of a structured counselling-based intervention to improve physical activity behaviour of adolescents and young adult cancer survivors - the randomized phase II Motivate AYA - MAYA trial

    Salchow, J., Koch, B., Mann, J., von Grundherr, J., Elmers, S., Dwinger, S., Escherich, G., Vettorazzi, E., Reer, R., Sinn, M., Baumann, F., Bokemeyer, C., Stein, A. & Jensen, W., 08.2021, In: CLIN REHABIL. 35, 8, p. 1164-1174 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  59. 71/m in reduziertem Allgemeinzustand mit Sklerenikterus

    Schönrock, M. & Sinn, M., 24.08.2021, In: ONKOLOGE. 2021, 27 supplement issue 1, p. 109-113

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Education

  60. Lymphocytopenia and Anti-CD38 Directed Treatment Impact the Serological SARS-CoV-2 Response after Prime Boost Vaccination in Patients with Multiple Myeloma

    Ghandili, S., Schönlein, M., Wiessner, C., Becher, H., Lütgehetmann, M., Brehm, T. T., Wiesch, J. S. Z., Bokemeyer, C., Sinn, M., Weisel, K. C. & Leypoldt, L., 24.11.2021, In: J CLIN MED. 10, 23, 5499.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 Next